XML 84 R84.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment Data (Schedule of Segment Reporting Information by Business Segment) (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended 6 Months Ended
Mar. 28, 2014
Mar. 29, 2013
Mar. 28, 2014
Mar. 29, 2013
Net sales $ 557.8 $ 585.3 $ 1,098.0 $ 1,089.3
Operating income 3.7 53.5 76.8 90.3
Intangible asset amortization (15.5) (8.8) (24.3) (17.7)
Restructuring and related charges, net (21.7) (6.9) (29.8) (7.9)
Separation costs (2.6) (14.4) (4.8) (26.4)
Restructuring related accelerated depreciation 0 (0.5) (0.1) (1.3)
Specialty Pharmaceuticals
       
Restructuring and related charges, net (2.7) (5.9) (2.7) (6.6)
Global Medical Imaging
       
Restructuring and related charges, net (18.5) (1.0) (26.6) (1.3)
Operating Segments
       
Net sales 546.7 [1] 573.5 [1] 1,074.8 [1] 1,063.4 [1]
Operating income 116.2 123.9 233.6 208.0
Operating Segments | Specialty Pharmaceuticals
       
Net sales 324.3 344.4 633.8 604.6
Operating income 105.9 105.0 218.9 140.0
Operating Segments | Global Medical Imaging
       
Net sales 222.4 229.1 441.0 458.8
Operating income 10.3 18.9 14.7 68.0
Corporate, Non-Segment
       
Net sales 11.1 [2] 11.8 [2] 23.2 [2] 25.9 [2]
Corporate and allocated expenses (72.7) [3] (40.3) [3] (97.9) [3] (65.7) [3]
Intangible asset amortization (15.5) (8.8) (24.3) (17.7)
Restructuring and related charges, net (21.7) [4] (6.9) [4] (29.8) [4] (7.9) [4]
Separation costs $ (2.6) $ (14.4) $ (4.8) $ (26.4)
[1] Amounts represent sales to external customers.
[2] Represents products that were sold to Covidien, our former parent company, which is discussed in Note 14.
[3] Includes administration expenses and certain compensation, environmental and other costs not charged to the Company's operating segments.
[4] Includes restructuring-related accelerated depreciation of $0.5 million for the three months ended March 29, 2013 and $0.1 million and $1.3 million million for the six months ended March 28, 2014 and March 29, 2013, respectively. Restructuring-related accelerated depreciation for the three months ended March 28, 2014 was immaterial.